These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22358341)

  • 21. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.
    Chatterjee B; Suri J; Suri JC; Mittal P; Adhikari T
    Sleep Med; 2014 Dec; 15(12):1547-53. PubMed ID: 25311833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.
    Liang SJ; Liou TH; Lin HW; Hsu CS; Tzeng CR; Hsu MI
    Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1167-72. PubMed ID: 22497305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
    Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
    Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.
    Apridonidze T; Essah PA; Iuorno MJ; Nestler JE
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1929-35. PubMed ID: 15623819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.
    Ehrmann DA; Liljenquist DR; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):48-53. PubMed ID: 16249284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.
    Rashidi H; Ramezani Tehrani F; Bahri Khomami M; Tohidi M; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():100-5. PubMed ID: 24411130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population.
    Johnstone EB; Davis G; Zane LT; Cedars MI; Huddleston HG
    Gynecol Endocrinol; 2012 Oct; 28(10):819-22. PubMed ID: 22475130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome.
    Costa EC; Sá JC; Soares EM; Lemos TM; Maranhão TM; Azevedo GD
    Gynecol Endocrinol; 2012 Jan; 28(1):12-5. PubMed ID: 21958393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
    Bil E; Dilbaz B; Cirik DA; Ozelci R; Ozkaya E; Dilbaz S
    J Obstet Gynaecol Res; 2016 Jul; 42(7):837-43. PubMed ID: 27071345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I; Algun E; Incecayir O; Ersoy K
    Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriasis and polycystic ovary syndrome: a new link in different phenotypes.
    Moro F; Tropea A; Scarinci E; Federico A; De Simone C; Caldarola G; Leoncini E; Boccia S; Lanzone A; Apa R
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():101-5. PubMed ID: 26115053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome.
    Detti L; Jeffries-Boyd HE; Williams LJ; Diamond MP; Uhlmann RA
    J Assist Reprod Genet; 2015 Dec; 32(12):1749-56. PubMed ID: 26542956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Frequency and risk factors for metabolic syndrome in adolescents and adults women with polycystic ovary syndrome].
    Pedroso DC; Melo AS; Carolo AL; Vieira CS; Rosa e Silva AC; dos Reis RM
    Rev Bras Ginecol Obstet; 2012 Aug; 34(8):357-61. PubMed ID: 23080278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
    Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
    Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.